{"id":17466,"date":"2019-01-22T11:23:42","date_gmt":"2019-01-22T16:23:42","guid":{"rendered":"http:\/\/www.aidslaw.ca\/site\/?p=17466"},"modified":"2022-09-25T21:48:58","modified_gmt":"2022-09-26T01:48:58","slug":"supporting-health-and-human-rights-in-drug-policy","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/supporting-health-and-human-rights-in-drug-policy\/","title":{"rendered":"Supporting Health and Human Rights in Drug Policy: Brief to the Minister of Health and Canadian Delegation to the UN Commission on Narcotic Drugs"},"content":{"rendered":"<p style=\"text-align: center;\">Prepared for the 62nd session of the UN Commission on Narcotic Drugs<br \/>\nand its High-Level Ministerial Segment<br \/>\nCanadian Civil Society Working Group on UN Drug Policy<br \/>\nJanuary 21, 2019<\/p>\n<p style=\"text-align: left;\">The High-Level Ministerial Segment of the 62nd Commission on Narcotic Drugs (CND) in Vienna on March 14th<br \/>\nand 15th is the next significant meeting of UN Member States to focus on global drug policy. In CND Resolution<br \/>\n60\/1, Member States decided that the Ministerial Segment will be the moment \u201cto take stock of the<br \/>\nimplementation of the commitments made to jointly address and counter the world drug problem, in particular<br \/>\nin light of the 2019 target date\u201d that was laid out in the 2009 Political Declaration and Plan of Action adopted by<br \/>\nthe Commission.1 The Ministerial Segment follows three years after the UN General Assembly Special Session<br \/>\non the World Drug Problem (UNGASS) in April 2016.<\/p>\n<p class=\"download-link-button\"><a class=\"download-link en\" title=\"HLM-Brief-2019-FINAL.pdf\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/17468\/?tmstv=1776496757\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[147],"publication_type":[173],"publication_language":[184],"class_list":["post-17466","publication22","type-publication22","status-publish","hentry","publication_topics-drug-policy","publication_type-briefing-papers","publication_language-english"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/17466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":4,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/17466\/revisions"}],"predecessor-version":[{"id":17472,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/17466\/revisions\/17472"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=17466"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=17466"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=17466"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=17466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}